Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Elektrokardiograf: Prof. Dr. Peter Kabo

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 56

Elektrokardiograf

Prof. dr. Peter Kabo

1. Irama

: Sinus
Bukan Sinus

2. Laju QRS
3. Aksis

Atrial Fibrilasi
SVT
Irama JUNSION
60-100 x/menit (normal)

: HR?
Regularitas
: Normal
RAD/LAD
Superior Aksis
: 0.20 Detik (Normal)

4. Interval PR
5. Morfologi
a. Gelombang P
b. Kompleks QRS

c. Segmen ST
d. Gel.T

: Normal P.Pulmonal P.Mitral


: Q patologis
RSR pattern di V1&V2
Interval-QRS (0.08 detik)
: ST-elevasi, ST-depresi
: Flat-T, Inverted-T, tall-T

PA interval : 0.01-0.45 detik


P dur
: 0.06 0.2 detik
Max
: 0.1 detik
AH interval
: 0.05-0.13 detik
PR-interval
: 0.2 detik
Max
: 0.24 detik
HV interval
: 0.03-0.05 detik
PRS dur
: 0.08 detik
Max
: 0.1 detik

6.7 x 20 = 134x/menit

300 : 5.8 = 52x/menit

3.3 x 50 = 165x/menit

Gambar 3.2. Perhitungan aksis


A. Aksis Normal
: Lead I: I= +4.5; lead aVF : +12.5; aksis = 72
B. Deviasi aksis ke kanan : Lead I = -10; lead aVF : +8; aksis = +140
C. Deviasi aksis ke kiri : Lead I = +5; lead aVF : -10; aksis = - 60

TERIMA KASIH

CARDIAC ARRHYTHMIAS
CLASSIFICATION :
1. Sinus Node diseases :
Sinus tachycardia / bradycardia
SA block
Wandering pace maker
Hypersensitive carotid sinus syndrome (SSS)

2. Disturbance of atrial rhytim :


Atrial fibrilation
Atrial flutter

3. Disturbance of AV junction rhytim :


Supraventricular tachycardia

4. Pre-excitation syndrome :
Woeff Parkinson White syndrome (S-wave)

5. Disturbance of ventricular rhytim :


Ventricular extra systole
Ventricular tachycardia
6. Heart Block :
1 o HB
2 o HB : - Wenckebach ( Mobits type I)
- Mobitz type II
o
3 HB (total AV block) : - Temporary pace-maker
- Permanent pace-maker
R/ : - Simpatomimetik : Ephedrin
- Anti cholinergic: Atropine

COMMON UNDERLYING DISEASES CAUSING


ARRHYTHMIAS
1. Ischemic Heart Disease :
Acute myocardial infarction
Myocardial ischemia ( HHD, LVH, CAD)
Left ventricle aneurysma
2. CARDIOMYOPATHY
3. Valvular Heart disease
4. Myocarditis
5. Congenital Hearth disease
6. Conduction system abnormalities :
Sinus R AV-node disease
By pass tract
7. Chronic pulmonary disease : Hypokemia
8. Endocrine : Thyrotoxicosis
9. Electrolide imbalance
10. Drug-induce : Sympathomimetic, caffeine
11. Increase Symphatetic / vagal activity

DRUG

Quinidine
Procamamide
Disopyramide
Lidocaine
Propafenone
Amiodarone

+
+
+

Sotalol

+
+

+
+
+

BIO
(%)

T
(hari)

40 %

4-10
3-4
4-10
2
2-32
25-60

100%

10

Doses
Loading

1 mg/kg BB
800-1600
(2 weeks)

Doses Maintenance
300-600
750
400-800
4-3-2-1mg/kg BB
450-900
100-400
80-320

DRUGS

INDICATIONS

Quinidine

AF

Procamamide
Disopyramide
Lidocaine

VES
VES
VES,VT

Propafenone
Amiodarone

VES,VT,AF,SVT
VES,VT,AF,SVT

Sotalol

VT,VES

ADVERSE EFFECTS
Cinchronism, Long QT
syndrome, Hypotension,
Diarrhea/Hepatitis,
Thrombocytopenia
Hypotension, Nausea, Lupus
(-) miotropic, Anti cholinergic :
dry mouth
Constipation, urine retention,
Glaukoma attack
Hypotension, nystagmus,
Seizure
Hypotension, Hepatic
disfunction, Pulmonary fibrosis,
Hypo/Hyper thyroidism, Cornea
microdeposit
Heart failure, Bradycardia

Tachycardia
Unstable

Stable

Serious sign or symptoms


prepare for immediate
cardioversion

Atrial fibrillation
Atrial flutter

Narrow-complex
tachycardias

Stable monomorphic
VT or Polymorphic VT

Narrow-complex Supra Ventricular Tachycardia (SVT)


Vagel Stimulation
Adenosine

Juctional
tachycardia

Heart function
preserved

Amiodarone, B-blokers,
Verapamil

EF < 40%

Amiodarone

Heart function
preserved
Paroxysmal SVT
EF < 40%

Ectopic / multifocal
atrial tachycardia

Heart function
preserved
EF < 40%

Verapamil, B-blokers,
Digoxin, Cardioversion,
Amiodarone, Sotalol,
Adenosine
Digoxin, Amiodarone
Verapamil, B-blockers,
Amiodarone
Amiodarone

ATRIAL FIBRILLATION / FLUTTER


CONTROL RATE
Normal Cardiac
Function

Verapamil
B-Blocker

Impaired Heart
(EF < 40% or CHF )

Digoxin

CONVERT RHYTIM
Amiodarone
Propafenone
Sulfas quinidine
DC Cardioversion

If AF > 48 hours duration : use anti arrithmic agents with extreme


caution patients not receiving adequate anti coagulation because of
possible embolic complication.
Delayed cardioversion :
Anti coagulation 3 weeks cardioversion anti coagulation 4 weeks

CLASSIFICATION OF ANTIARRHYTMIC
DRUGS
I. Sodium channel blockers
A. Sodium channel (++)
Blocks K+ effluks (+)
B. Sodium Channel (+)

C. Sodium Channel (+++)

Disopyramide
Quinidine
Procainamide
Lidocaine
Mekiletine
Tocainide
Flecamide, Encamide,
Propafenone

II. Anti adrenergic

Beta blockers

III. K+ channel effluks blockers


also Na+ Blockers

Amiodarone
Sotalol

IV. Ca++ channel blockers

Verapamil, Diltiazem

V. Autonomic effects
Vagal stimulation
Adenosine receptor activation

Digoxin
Adenosine

Mechanisms of Antiarrhytmic Drug Action


Decreased Phase 4 Slope

B-blocker

Increased Threshold

Na+ channel
blocker
Ca++ channel
blocker

Increased Max-diastolic
potential

Adenosine
Acetylcholine

Increased action potential


duration

K+ channel
blocker

Antiarrhytmic drugs can cause


arrhytmias
Some arrthythmias should not be treated

Mechanisms of Cardiac Arrhytmias


1. Enhanced Automaticity :
2. Triggered Automaticity :

Sinus tachycardia
Multifocal atrial tachycardia. VES

Delayed after depolarization

Early after depolarization

3. Reentry
Atrial fibrillation (AF)
Atrial Flutter
Supraventricular tachycardia (SVT)
Ventricular tachycardia (VT)
Woeff-Parkinson-White Syndrome

4. Block
1o AV block
2o AV block
3o AV block (Total AV Block)

VT. Torsade de pointes

Narrow QRS Complex


Retrograde P
Vent-rate : 140 200 x / min
Vagal Maneuver Response
Wide QRS Complex, V1(+), LAD/Superior
AV dissociation / fusion beat
Vent-rate : 150 250 x / min
Vagal Maneuver No Response

You might also like